Calidi Biotherapeutics completes $3.9 million direct stock sale

On February 7, 2025, the United States Securities and Exchange Commission (SEC) granted effectiveness to a registration statement on Form S-3 (File No. 333-284229). This registered direct offering is significant for the company involved, as it allows for the lawful sale of securities directly to investors without the need for a broker.

The SEC’s approval of the registration statement marked a crucial moment for the company, signaling the green light for them to proceed with the registered direct offering. This method of offering securities provides the company with a streamlined process to raise capital by selling shares directly to investors, bypassing traditional underwriters or brokers.

By cutting out the middleman, the company can potentially save on fees and expenses associated with a traditional offering. This direct approach also allows for more control over the pricing and timing of the offering, giving the company greater flexibility in managing its capital-raising activities.

The registration statement on Form S-3 is a comprehensive document that discloses important information about the offering. It includes details about the company’s business operations, financial performance, and the securities being offered. Investors rely on this document to make informed decisions about whether to participate in the offering.

The SEC plays a crucial role in reviewing and approving registration statements to ensure that investors are provided with accurate and timely information. The effectiveness of the registration statement indicates that the SEC has completed its review process and deemed the document compliant with regulatory requirements.

For the company involved, the approval of the registration statement opens up new opportunities for fundraising and growth. The direct offering allows them to engage directly with investors and tailor the offering to meet their specific needs and preferences.

Overall, the SEC’s approval of the registration statement on Form S-3 represents a significant milestone for the company, paving the way for them to proceed with the registered direct offering. This method of fundraising provides the company with greater control and flexibility, allowing them to raise capital in a more efficient and cost-effective manner.